ProHealth health Resource
 SUBSCRIBE TO OUR FREE E-NEWSLETTERS  
Click Here to Preview
Log In
Catalog Quick Order
Your Account
Shopping Cart
 Check Out
ProHealth: News, Research, Vitamins & Supplements About ProHealth ProHealth ImmuneSupport.com ProHealth Online Vitamin & Supplement Store ProHealth Treatment & Research Library ProHealth Community ProHealth Vitamins & Supplements Catalog
Your Purchase Helps Fund Health Research
Celebrating 20 Years
Explore Our Health Sites
ProHealth Vitamin and Supplement Catalog
Your resource for specialty nutritional supplements, books, DVDs, resources for better living, health news & more!
ProHealth Health & Wellness Research & News Catalog
Your Purchases Help Fund Ongoing Research
 
 
Search our extensive library for information, solutions & support
Site
Message Board  
Abstracts
Newsletters  
Articles
Products  

Abstract: Clinical Endocannabinoid Deficiency (CECD): Can this Concept Explain Therapeutic Benefits of Cannabis in Migraine, Fibromyalgia, Irritable Bowel Syndrome and other Treatment-Resistant Conditions?

May 26, 2004

Neuroendocrinol Lett. 2004 Feb-Apr;25(1/2):31-39. Russo EB. Senior Medical Advisor, GW Pharmaceuticals, 2235 Wylie Avenue, Missoula, MT 59802, USA. erusso@montanadsl.net OBJECTIVES: This study examines the concept of clinical endocannabinoid deficiency (CECD), and the prospect that it could underlie the pathophysiology of migraine, fibromyalgia, irritable bowel syndrome, and other functional conditions alleviated by clinical cannabis. METHODS: Available literature was reviewed, and literature searches pursued via the National Library of Medicine database and other resources. RESULTS: Migraine has numerous relationships to endocannabinoid function. Anandamide (AEA) potentiates 5-HT1A and inhibits 5-HT2A receptors supporting therapeutic efficacy in acute and preventive migraine treatment. Cannabinoids also demonstrate dopamine-blocking and anti-inflammatory effects. AEA is tonically active in the periaqueductal gray matter, a migraine generator. THC modulates glutamatergic neurotransmission via NMDA receptors. Fibromyalgia is now conceived as a central sensitization state with secondary hyperalgesia. Cannabinoids have similarly demonstrated the ability to block spinal, peripheral and gastrointestinal mechanisms that promote pain in headache, fibromyalgia, IBS and related disorders. The past and potential clinical utility of cannabis-based medicines in their treatment is discussed, as are further suggestions for experimental investigation of CECD via CSF examination and neuro-imaging. CONCLUSION: Migraine, fibromyalgia, IBS and related conditions display common clinical, biochemical and pathophysiological patterns that suggest an underlying clinical endocannabinoid deficiency that may be suitably treated with cannabinoid medicines. PMID: 15159679 [PubMed - as supplied by publisher]

DISCUSS THIS ARTICLE   (2 existing comments) Post a Comment 
health Research Articles
313rd most popular article of 759 discussed articles
Sort by: Date | Score | Username

YES, I kept telling my doctor cannabis helps in so many ways!
Posted by: firstrala
Dec 13, 2007
I am also bipolar and have been on many LEGAL medications for bipolar, fibromyalgia, IBS and nothing worked or had such drastic side effects, I had to stop. After 3 years and seven months 'clean', I began to treat the anxiety and fibro pain with cannabis. Not only am I able to function much better without as much pain, my IBS symptoms are GONE. I haven't had an ER visit since!! KEEP LEARNING AND RESEARCH ALIVE! Short term memory problems are a side effect I can live with.
Reply Reply

forget what u know about cannabis
Posted by: kikky
Apr 13, 2009
I have used cannabis for appetite stimulation and to help manage stress for years. It would not surprise me that there are many other applications. I am in excellent health and can say the myths surrounding cannabis use are just the result of decades of negative propoganda aimed to secure the cotton industry's future. Short term memory loss is not a permanent side affect.
Reply Reply
<i>Abstract</i>: Clinical Endocannabinoid Deficiency (CECD): Can this Concept Explain Therapeutic Benefits of Cannabis in Migraine, Fibromyalgia, Irritable Bowel Syndrome and other Treatment-Resistant Conditions? Article Tools
Print Page Print Page Email Article Email Article
Discuss Discuss
  Rate This
Featured Vitamins, Supplements, and Health Products
Weight Loss CD by Health Journeys Weight Loss CD by Health Journeys
Guided Imagery CD
Quercetin / Bromelain Complex Quercetin / Bromelain Complex
Promote healthy inflammation response
Miracle Reds® Bars - Berri Berri Flavor Miracle Reds® Bars - Berri Berri Flavor
With goji berry, pomegranate, acai and mangosteen
Austin HealthMate Jr (any junior) wheel plate Austin HealthMate Jr (any junior) wheel plate
Can be ordered with any HealthMate Jr
Glucosamine, MSM & Arnica Lotion by Now Foods Glucosamine, MSM & Arnica Lotion by Now Foods
Helps relieve aches & pains
Most Viewed Articles & Abstracts
CFS Advisory Committee Meeting - Live Online Oct 29-30 [more]

Flu – What Is It That Stops Many People from Getting It? [more]

Body manufactures potent anti-inflammatory using DHA in fish oils - discovery holds much promise [more]

Intimacy - What to Do When ME/CFS or FM Becomes a Third Wheel in Your Relationship [more]

Dr. Charles Shepherd Updates His Advisory on Swine Flu & the Vaccine for ME/CFS Patients – A Highly ... [more]

ProHealth Vitamin and Supplement SmartSavings Club
Security Enabled AlertSite is a leading provider of Web site monitoring and performance management solutions that help businesses ensure optimum Web experiences for their customers. TrustE Better Business Bureau BizRate Customer Certified (GOLD) Site

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
ADVANCED MEDICAL LABS   |   WHOLESALE   |   AFFILIATES   |   CONTACT US   |   PRIVACY   |   GLOSSARY   |   CUSTOMER SERVICE   |   RELATED SITES   |   RSS
Email us or Call toll-free 800-366-6056 · Monday through Friday, 7 a.m.-5 p.m. Pacific Time
International Callers dial 001.805.564.3064
Copyright © 2009 ProHealth, Inc.